Skip to main content

Want a detailed portfolio tracker?

BeyondSpring (BYSI) P/E (2024 - 2026)

BeyondSpring (BYSI) P/E from Apr 1, 2024 to Jul 21, 2026. The TTM BeyondSpring (BYSI) P/E is -6.66. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of BeyondSpring (BYSI)

YearP/EChange
2026-6.66-90.19%
2025-67.92+1081.29%
2024-5.75N/A

Comparison BeyondSpring (BYSI) P/E with competitors

BeyondSpring (BYSI) P/E is -6.66.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-101.12%
FGENFibroGen Inc0.24-103.60%
CHRSCoherus Biosciences Inc0.85-112.74%
FBIOFortress Biotech Inc0.95-114.25%
ORMPOramed Pharmaceuticals Inc1.50-122.56%
AGENAgenus Inc3.01-145.18%
INVAInnoviva Inc3.15-147.35%
VXRTVaxart Inc3.55-153.29%
CRMDCorMedix Inc3.63-154.47%
CVACCureVac N.V.4.45-166.74%
GLPGGalapagos NV4.86-172.94%
SRPTSarepta Therapeutics Inc4.88-173.29%
ABEOAbeona Therapeutics Inc5.39-180.87%
ABUSArbutus Biopharma Corp5.60-184.00%
ZVRAZevra Therapeutics Inc5.89-188.38%
SPROSpero Therapeutics Inc6.23-193.50%
CGENCompugen Ltd6.31-194.78%
RIGLRigel Pharmaceuticals6.87-203.16%
SLXNSilexion Therapeutics Corp7.30-209.52%
OMEROmeros Corporation9.26-238.99%
AUPHAurinia Pharmaceuticals Inc9.58-243.88%
PLXProtalix BioTherapeutics Inc10.89-263.49%
ACADAcadia Pharmaceuticals Inc11.73-276.06%
TBPHTheravance Biopharma Inc12.26-284.07%
ADMAAdma Biologics Inc12.42-286.41%
HRMYHarmony Biosciences Holdings Inc13.82-307.46%
SABSSAB Biotherapeutics Inc14.14-312.20%
NAGENiagen Bioscience Inc14.82-322.44%
INCYIncyte Corp15.82-337.52%
REGNRegeneron Pharmaceuticals Inc15.86-338.03%
PBYIPuma Biotechnology Inc17.32-359.93%
CPRXCatalyst Pharmaceuticals Inc17.44-361.79%
EXELExelixis Inc17.54-363.27%
TGTXTG Therapeutics Inc18.97-384.71%
MDXGMimedx Group Inc20.55-408.52%
XOMAXOMA Royalty Corp22.87-443.39%
ARGXArgen X SE24.30-464.76%
CTMXCytomX Therapeutics Inc24.82-472.61%
XOMAOXOMA Royalty Corp25.34-480.47%
HALOHalozyme Therapeutics Inc25.62-484.66%
XOMAPXOMA Royalty Corp25.67-485.36%
VRTXVertex Pharmaceuticals Inc27.99-520.25%
RPRXRoyalty Pharma plc - Class A28.69-530.65%
SLNOSoleno Therapeutics Inc29.02-535.57%
ASNDAscendis Pharma A/S30.09-551.64%
LGNDLigand Pharmaceuticals Inc - Class B37.91-669.13%
APLSApellis Pharmaceuticals Inc39.02-685.78%
BMRNBiomarin Pharmaceutical Inc42.21-733.68%
KRYSKrystal Biotech Inc45.34-780.69%
ONCBeiGene Ltd69.54-1143.93%
PHARPharming Group N.V.75.03-1226.27%
TECHBio-Techne Corp101.96-1630.59%
VCELVericel Corp109.92-1750.12%
ALNYAlnylam Pharmaceuticals Inc117.96-1870.88%
GMABGenmab140.29-2206.03%
TLXTelix Pharmaceuticals Ltd162.15-2534.22%
CORTCorcept Therapeutics Inc212.86-3295.39%